| Epithelial-mesenchymal transition in prostate cancer: an overview M Montanari, S Rossetti, C Cavaliere, C D'Aniello, MG Malzone, ... Oncotarget 8 (21), 35376, 2017 | 189 | 2017 |
| Microbiota effects on cancer: from risks to therapies D Rea, G Coppola, G Palma, A Barbieri, A Luciano, P Del Prete, ... Oncotarget 9 (25), 17915, 2018 | 184 | 2018 |
| Micrornas in prostate cancer: an overview D Vanacore, M Boccellino, S Rossetti, C Cavaliere, C D'Aniello, ... Oncotarget 8 (30), 50240, 2017 | 138 | 2017 |
| Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the … E Verzoni, G Cartenì, E Cortesi, D Giannarelli, A De Giglio, R Sabbatini, ... Journal for immunotherapy of cancer 7, 1-9, 2019 | 124 | 2019 |
| Extragonadal germ cell tumors: not just a matter of location. A review about clinical, molecular and pathological features A Ronchi, I Cozzolino, M Montella, I Panarese, F Zito Marino, S Rossetti, ... Cancer medicine 8 (16), 6832-6840, 2019 | 100 | 2019 |
| Physician attitudes and perceptions of complementary and alternative medicine (CAM): a Multicentre Italian study M Berretta, L Rinaldi, R Taibi, P Tralongo, A Fulvi, V Montesarchio, ... Frontiers in oncology 10, 594, 2020 | 68 | 2020 |
| Testicular cancer from diagnosis to epigenetic factors M Boccellino, D Vanacore, S Zappavigna, C Cavaliere, S Rossetti, ... Oncotarget 8 (61), 104654, 2017 | 67 | 2017 |
| Metabolic syndrome, endocrine disruptors and prostate cancer associations: biochemical and pathophysiological evidences V Quagliariello, S Rossetti, C Cavaliere, R Di Palo, E Lamantia, ... Oncotarget 8 (18), 30606, 2017 | 65* | 2017 |
| Coffee decreases the risk of endometrial cancer: a dose–response meta-analysis of prospective cohort studies A Lafranconi, A Micek, F Galvano, S Rossetti, L Del Pup, M Berretta, ... Nutrients 9 (11), 1223, 2017 | 60 | 2017 |
| Biomarkers of prognosis and efficacy of anti-angiogenic therapy in metastatic clear cell renal cancer C D'Aniello, M Berretta, C Cavaliere, S Rossetti, BA Facchini, G Iovane, ... Frontiers in oncology 9, 1400, 2019 | 52 | 2019 |
| Influenza vaccine indication during therapy with immune checkpoint inhibitors: a transversal challenge. The INVIDIa study M Bersanelli, D Giannarelli, P Castrignanò, G Fornarini, S Panni, ... Immunotherapy 10 (14), 1229-1239, 2018 | 50 | 2018 |
| Current status of targeted therapies in advanced gastric cancer F De Vita, F Giuliani, N Silvestris, S Rossetti, A Pizzolorusso, ... Expert Opinion on Therapeutic Targets 16 (sup2), S29-S34, 2012 | 50 | 2012 |
| Health-related quality of life and psychosocial implications in testicular cancer survivors. A literature review. F Cappuccio, S Rossetti, C Cavaliere, G Iovane, R Taibi, C D'ANIELLO, ... European Review for Medical & Pharmacological Sciences 22 (3), 2018 | 41 | 2018 |
| Cisplatin can be safely administered to ovarian cancer patients with hypersensitivity to carboplatin A Bergamini, C Pisano, M Di Napoli, L Arenare, C Della Pepa, R Tambaro, ... Gynecologic oncology 144 (1), 72-76, 2017 | 41 | 2017 |
| Therapeutic options for first-line metastatic castration-resistant prostate cancer: Suggestions for clinical practise in the CHAARTED and LATITUDE era M Tucci, O Caffo, C Buttigliero, C Cavaliere, C D'aniello, M Di Maio, ... Cancer treatment reviews 74, 35-42, 2019 | 38 | 2019 |
| Rectal/urinary toxicity after hypofractionated vs conventional radiotherapy in low/intermediate risk localized prostate cancer: systematic review and meta analysis R Di Franco, V Borzillo, V Ravo, G Ametrano, S Falivene, F Cammarota, ... Oncotarget 8 (10), 17383, 2017 | 37 | 2017 |
| Cabozantinib after a previous immune checkpoint inhibitor in metastatic renal cell carcinoma: a retrospective multi-institutional analysis R Iacovelli, C Ciccarese, G Facchini, M Milella, F Urbano, U Basso, ... Targeted Oncology 15, 495-501, 2020 | 34 | 2020 |
| Role of DNA repair machinery and p53 in the testicular germ cell cancer: a review FJ Romano, S Rossetti, V Conteduca, G Schepisi, C Cavaliere, ... Oncotarget 7 (51), 85641, 2016 | 33 | 2016 |
| Statin use and survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide after docetaxel failure: the international … JA Gordon, C Buonerba, G Pond, D Crona, S Gillessen, G Lucarelli, ... Oncotarget 9 (28), 19861, 2018 | 32 | 2018 |
| Radiosurgery and stereotactic radiotherapy with cyberknife system for meningioma treatment R Di Franco, V Borzillo, V Ravo, S Falivene, FJ Romano, M Muto, ... The Neuroradiology Journal 31 (1), 18-26, 2018 | 31 | 2018 |
